At its in-person meeting on May 8, 2017, in Washington, D.C., the Board approved the development of two new PCORI Funding Announcements (PFAs) that together will offer up to $41 million in support of comparative clinical effectiveness research (CER). The PFAs will focus on two important topics: the best ways to deliver medication-assisted treatment for opioid use disorders to pregnant women, and how to most effectively manage symptoms in patients with advanced illness. Each responds to key concerns voiced by healthcare decision makers. (Read more)
The Board also adopted the newest version of the PCORI Methodology Standards. The updates include new standards on analysis of clustered data, inclusion of a formal study protocol in public data, and approaches to selection and usage of data networks, among other changes. (Read more)
Each in-person Board meeting is open to the public. Registration to attend in-person meetings is not required.
This meeting was available via teleconference/webinar for anyone unable to attend in person.
Each in-person public Board meeting includes a public comment period. Individuals could register to provide comment on-site, and those unable to attend in person could provide comment via telephone. (Guidelines for Public Comments)
Teleconference Audio Recording